欢迎来到应届生求职网-中国领先的大学生求职网站
当前位置:首页 » 上海招聘 » [上海]上海德琪医药科技有限公司

[上海]上海德琪医药科技有限公司

  1. 发布时间:2020-07-08
  2. 工作地点:上海
  3. 职位类型:全职
  4. 来源:前程无忧(51JOB)
  5. 职位:Medical Associate 医学助理
职能类别:生物工程/生物制药
职能类别:临床研究员

Responsibilities:
- Research literature to assist with the development of draft scientific presentations, study protocol and related documents for the team to review
- Provide research and writing support to assigned teams and new business efforts
- Perform literature searches (PubMed, Internet, etc) and summarize findings
- Work closely with medical directors to ensure on-target communication and clinical accuracy of content
- Represent the company at selected educational and client meetings
- Attend weekly team status meeting

Education or Equivalent: (Minimum required to perform job)
- M.S. in health sciences(Medical background preferred)
- An advanced degree in health science is desirable
- Experience with a medical education company or clinical equivalent preferred
- Knowledge/Skills Requirements:(List unique knowledge skills, or problem-solving requirements)
- Clinical experience/knowledge of diseases and pharmaceutical agents
- Should be proficient in MS Word, PowerPoint, and Outlook.
- Research skills on PubMed and the Web
- Excellent communication skills
- Must work well in a team-oriented environment
- Ability to meet deadlines while working on multiple, parallel projects

Business Environment
- Medical Associates must be able to work both independently and in a team structure. They should be motivated and dedicated to building their skills and advancing their capabilities in the area of medical strategy.

 

公司简要介绍:

公司名称:上海德琪医药科技有限公司
公司类型:外资(欧美)
公司规模:50-150人
公司介绍:德琪医药是一家专注于新药开发和销售的创新药公司,专注于解决亚洲地区未被满足的医疗需求,并力争为中国及亚太地区的患者提供领先的抗癌药物。2017年4月13日,全球创新药领导企业新基药业(Nasdaq:CELG)成为德琪医药的长期战略合作伙伴并入股德琪。目前,德琪医药拥有五个临床研发阶段的产品:ATG-010是一款在多发性骨髓瘤(multiple myeloma, MM)、弥漫性大B细胞淋巴瘤(diffuse large B-cell lymphoma, DLBCL)及多种实体瘤分别处于NDA申报及临床二/三阶段的在研产品;ATG-008已在包括中国大陆、中国台湾和韩国在内的多个地区展开亚太多中心肝癌临床研究;ATG-016和ATG-019是两款处于临床一/二期的专注于癌症治疗的在研产品,正在进行关于治疗包括骨髓增生异常综合征(myelodysplastic syndromes, MDS)、结肠直肠癌、前列腺癌在内的多个癌症种类的临床研究;ATG-527是一款在研抗病毒药品,目前正在进行关于治疗流感、呼吸道合胞病毒(respiratory syncytial virus,RSV)及人类疱疹病毒(epstein-barr virus,EBV)感染等相关疾病的临床研究,其已完成一期临床研究。


Copyright ©前锦网络信息技术(上海)有限公司 版权所有
网站备案/许可证号:沪ICP备12015550号-13 | 上海市公安局徐汇分局网监中心备案编号:3101040220 | 触屏版